Big Rock Partners Acquisition Corp is a blank check company.
On 12/14/2020 the company announced a pending merger wth NueroRX, Inc., a a clinical stage, small molecule pharmaceutical company. NeuroRx develops novel therapeutics for the treatment of COVID-19 (RLF-100 or “ZYESAMI(aviptadil)”) and Bipolar Depression (NRX-100, 101).
$40.26 -2.21 (-5.20%)
As of 02/25/2021 11:29:14 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.